Börsipäev 16. november
Kommentaari jätmiseks loo konto või logi sisse
-
Reede hilisõhtul Pariisis aset leidnud terrorirünnak on olnud peamiseks kõneaineks üle terve maailma, raputades kindlustunnet nädalavahetusel nii Lähis-Ida börsidel kui ka täna hommikul Aasias. Nädal kujunes finantsturgude jaoks juba enne seda üsna keeruliseks, kui Ühendriikides langes S&P 500 -3,6%, Euroopas kaotas Stoxx 600 -2,7% ning nafta -8% kukkumine hoidis energiasektorit surve all.
Väga tugeva oktoobri taustal pole siiski imekspandav, et üleostetud aktsiaturgudel võetakse kasumit, eriti kuna juhtivaks teguriks oli Ühendriikides edasi lükkunud intressimäära kergitamise ootus, mida prognoositust palju paremaks osutunud oktoobrikuu tööturu raport murdis. Macy’se ning Nordstromi pettumustvalmistavad numbrid ning lisaks konsensusele alla jäänud USA oktoobrikuu jaemüük lisasid samuti õli tulle, kuid nüüd ollakse üsna lähedal juba ülemüüdud tingimustele, mis võib veel mõne müügipäeva järel lühiajalist leevendust pakkuda.
Tõenäoliselt jääb Pariisi terrorirünnak juhtima lähiajal turuosaliste meelestatust, seda enam et majandusuudiste valik on täna üsna tagasihoidlik. Mitmete Euroopa Keskpanga liikmete esinemised võivad heita valgust valmisolekule detsembri istungil deposiidi intressimäära langetada ning võlakirjade ostuprogrammi suurendada.
10.30 Euroopa Keskpanga asepresident Vitor Constancio esineb kõnega
12.00 Eurotsooni inflatsioon (oktoobri lõplik)
12.15 Euroopa Keskpanga president Mario Draghi esineb kõnega
15.30 USA NY FEDi töötleva tööstuse küsitlus (november)
18.00 Euroopa Keskpanga nõukogu liige Coeure esineb kõnega -
Jaapani sisemajanduse kogutoodang kahanes kolmandas kvartalis annualiseeritult -0,8% (Q2 -0,7%), mis olin nõrgem kui oodatud -0,2%, kuid detailsem vaade näitab, et peamiseks negatiivseks mõjutajaks oli muutus varudes. Majandusest 60% moodustav eratarbimine kasvas QoQ 0,5% vs oodatud 0,4%, millele lisaks revideeriti teise kvartali -0,7% langus -0,6% peale. Ettevõtted jäävad investeeringute tegemisel endiselt tagasihoidlikuks, vhendades kapitalikulutusi QoQ -1,3% pärast -1,2% langust teises kvartalis (oodati -0,5%).
-
Kuigi Mario Draghi sõnul on tuuminflatsiooni trend eurotsoonis nõrgenenud, siis tegelikud numbrid seda hetkel ei peegelda. Eurotsooni oktoobri inflatsioon (autosid ja kütust arvestamata) revideeriti 0,1pp võrra kõrgemale 1,1% peale, mis on kõrgeim alates 2013.a ning oktoobri algusest on ülespoole liikunud ka finantsturgude pikema aja inflatsiooniootused.
-
Suurinvestorite aruanded näitavad, kuidas on oma positsioone kolmandas kvartalis muudetud.
Berkshire Hathaway discloses updated portfolio positions in 13F filing:
Increased positions in: SU (to ~30 mln shares from ~22.4 mln shares), FOXA (to ~9 mln from ~6.2 mln)
Decreased positions in: CBI (to ~2 mln shares from ~9.3 mln shares), LMCA (to ~23.2 mln from ~12 mln)
Closed positions in: VIAB (from ~5.6 mln shares)
Buffett's Berkshire also disclosed a 'new' 325 mln share position in Kraft Heinz (KHC) following the completion of its merger, and a 59 mln share position in AT&T (T) following completion of acquisition of DirecTV.
Hayman Capital discloses updated portfolio positions in 13F filing;
New positions in: ADHD (~0.6 mln shares), IPXL (~0.6 mln), ESES (~2.1 mln), DBVT (~0.3 mln), DNAI (422K)
Increased positions in: YPF (to ~2.3 mln shares from ~1.3 mln shares), NMIH (to ~7.4 mln from ~5.5 mln)
Decreased positions in: MYL (to ~0.1 mln shares from ~0.8 mln shares)
Closed positions in: CJES (from ~1.3 mln shares), OAS (from ~1.2 mln), PVA (from ~3.2 mln), RES (from ~1.1 mln), SN (from ~1.5 mln), WLL (from ~0.6 mln), SPN (614K), MTDR (632K), BCEI (805.9K)
Appaloosa Management (David Tepper) discloses updated portfolio positions in 13F filing:
New positions in: LUV (~1.6 mln shares), WMIH (~16.9 mln), EXP (~0.8 mln)
Increased positions in: DAL (to ~6.1 mln shares from ~4.3 mln shares)
Decreased positions in: GM (to ~13.3 mln shares from ~19.2 mln shares), GT (to ~5.9 mln from ~10 mln), AAPL (to ~1.3 mln from ~2.5 mln), KBR (to ~0.5 mln from ~1.6 mln), UAL (to ~0.5 mln from ~1.5 mln)
Closed positions in: BABA (from ~1.4 mln shares), BAC (from ~1.9 mln), MAS (from ~2.4 mln), RF (from ~3 mln), DHI (from ~1.1 mln)
Note: David Tepper will be presenting on Monday at the Robin Hood Conference
Trian Fund Management discloses updated portfolio positions in 13F filing:
New positions in: GE (~90.6 mln shares)
Increased positions in: PNR (to ~13 mln shares from ~6.8 mln shares), SYY (to ~41.4 mln from ~10.2 mln)
Decreased positions in: IR (to ~2.8 mln shares from ~7.3 mln shares), WEN (to ~40.8 mln from ~54.0 mln) -
New Yorgi piirkonna töötleva tööstuse aktiivsusindeks näitas novembris vaid marginaalset paranemist, kerkides -11,36 punkti pealt -10,74 punktile (oodati -6,5). Uute tellimuste indeks kerkis -18,91 punktilt -11,82 punktile ning tööhõive indeks -8,49 punktilt -7,27 punktile.
-
Gapping up
b]In reaction to strong earnings/guidance:[/b] TIK +10.7%, OHGI +8.5%, BCOM +5.3%, (co's subsid posted earnings update), PLUG +2.2%, YOD +1%
M&A news: ERIC +1.6% (Friday rumors of acquisition by Cisco (CSCO); states recent partnership had no discussions of merger)
Select metals/mining stocks trading higher: AUY +2.7%, AEM +1.6%, SLW +1.5%, GDX +1%, BHP +0.7%, GLD +0.7%
Select oil/gas related names showing strength: RDS.A +1.2%, RIG +1.1%, BP +0.7%, CHK +0.5%, TOT +0.4%
Other news: NLST +21.5% (U.S. Federal Court of Appeals upheld the validity of all claims in the reexamination of U.S. Pat. No. 7,532,537 brought by Inphi (IPHI)), NVET +16.8% (reports results of NV-01 pivotal study in dogs; study met primary endpoint), BIOL +13.3% (Jack W. Schuler, ~20% active stake, discloses entry into standstill agreement), ARWR +7.4% (presents data showing robust sustained anti-viral effects with ARC-520 in Hepatitis B), FCEL +7.4% (still checking), GLPG +6.1% (still checking; rebounding pre-mkt following last week's declines), ARRY +5.5% (Array Biopharma and Pierre Fabre announces collaboration to develop and commercialize Array's late-stage novel oncology products, binimetinib and encorafenib), PLX +5.2% (files for $100 mln mixed securities shelf offering; also initiates a Phase III Clinical Trial for PRX-102 to treat Fabry Disease, following a successful end-of-phase II meeting with the FDA), NATH +3.6% ( increases the price range of its previously announced Dutch Auction tender offer), MBT +3.2% (cont strength), SODA +3.1% (CEO purchases 30k ordinary shares on the open market), CGIX +3% (Frigate Ventures discloses 6.5% passive stake in 13G filing), IBN +2.4% (outperformer in the Sensex today), SUNE +1.8% (profiled in Barrons), VIPS +1.7% (pre-mkt rebound after last week's declines)
Analyst comments: PRGO +1.8% (upgraded to Buy from Neutral at UBS), BUD +1.8% (upgraded to Outperform at Exane BNP Paribas ), NVDA +1% (upgraded to Buy from Hold at Canaccord Genuity ), ORCL +0.9% (added to Conviction Buy List at Goldman), AV +0.7% (upgraded to Buy at BofA/Merrill)
Gapping down
In reaction to disappointing earnings/guidance: DDS -10.3%, ASTI -7.9%, SORL -4.6%, MOBI -4.6%, AUMN -3.1%
M&A news: HOT -5.1% (Starwood Hotels to be acquired by Marriott (MAR) for ~$12.2 bln, or roughly $79.88/share in cash/stock), SYT -2.8% (weakness pre-mkt, may be giving back gains from Friday after no new news on M&A talks), MAR -1.2% (see HOT)
Select Travel and Leisure related names showing weakness after Paris attacks: CCL -1.9%, EXPE -1.8%, CTRP -1.6%, DAL -1.5%, ALK -1.2%, RCL -0.8%
Other news: CLVS -59% (announces that the FDA requested additional clinical data for use in the efficacy analysis for both the 500mg and 625mg BID dose patient groups for rociletinib), KBIO -52.2% (to wind down operations, engages the Brenner Group to lead efforts), HOT -5.3% ( to be acquired by Marriott (MAR) for ~$12.2 bln, or roughly $79.88/share in cash/stock), FIVE -4.8% (downgraded to Hold from Buy at Deutsche Bank), RPTP -4.8% (provides additional results on RP103, re-iterating there was no difference in the response rate between RP103 and placebo), NBG -1.9% (cont weakness), KKR -1.5% (filess for ~2.63 mln share offering of common units by selling unitholders), TI -1% (Telecom Italia receives request from Vivendi (VIVHY) to supplement the agenda of upcoming shareholders meeting; Vivendi planning to appoint four directors)
Analyst comments: CNHI -4.7% (downgraded to Underweight from Neutral at JP Morgan ), MNKD -3.7% (downgraded to Neutral at Griffin Securities ), BBY -1.4% (downgraded to Sector Perform at RBC Capital Mkts)
Briefing.com
